A judge in a Texas widow’s lawsuit regarding the Merck & Co. drug Vioxx has reduced a $32 million jury verdict to about $7.75 million, citing Texas’ recently enacted caps on punitive damages.

A spokesman for Merck’s outside legal counsel said the company was seeking a new trial based on “the undisclosed financial relationship” between the plaintiff and one of the jurors.